Androgenetic Alopecia: Combining Medical and Surgical Treatments

Dermatologic Surgery

Volumn 29, Issue 11, 2003, Pages 1130-1134

  Bouhanna, Pierre ^a,b  

^a SAINT LOUIS HOSPITAL   (France)

^b NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FINASTERIDE; MINOXIDIL;

ARTICLE; DISEASE CLASSIFICATION; DRUG EFFICACY; DYNAMIC MULTIFACTORIAL CLASSIFICATION; FOLLOW UP; HAIR FOLLICLE; HAIR GROWTH; HAIR LOSS; HAIR TRANSPLANTATION; HUMAN; MALE TYPE ALOPECIA; OUTCOMES RESEARCH; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

ALOPECIA; COMBINED MODALITY THERAPY; ENZYME INHIBITORS; FEMALE; FINASTERIDE; HAIR FOLLICLE; HUMANS; MALE; MINOXIDIL; SKIN TRANSPLANTATION; VASODILATOR AGENTS;

EID: 0242710196     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2003.29352.x     Document Type: Article

References (19)

1. Hamilton JB. Male hormone stimulation is prerequisite and an incitant in common baldness. Am J Anat 1942;71:451-80.
2. Bergfeld WF. Androgenetic alopecia: an autosomal dominant disorder. Am J Med 1995;98(Suppl 1A):95S-98S.
3. Olsen EA. Androgenetic alopecia. In: Olsen EA, ed. Disorders of Hair Growth: Diagnosis and Treatment. New York: McGraw-Hill, 1994:257-83.
4. Sawaya ME, Price VH. Different levels of 5 alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 1997;109:296-300.
5. Hamilton JB. Patterned loss of hair in man: types and incidence. Ann N Y Acad Sci 1951;53:708-28.
6. Ludwig E. Classifications of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977;97:249-57.
7. Bouhanna P. Multifactorial classification of male and female androgenetic alopecia. Dermatol Surg 2000;26:555-61.
8. Bouhanna P. Classification dynamique plurifactorielle des alopécies androgénétiques masculines et féminines. Nouv Dermatol 2000;19:540-6.
9. Kaufmann KD, Olsen EA, Whiting DA, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998;39:578-89.
10. Trancik R, Rundegren J. Topical minoxidil 5 percent in the treatment of male androgenetic alopecia. J Invest Dermatol, in press.
11. Price VH, Menefee E, Strauss PC. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment. J Am Acad Dermatol 1999;41(5 Pt 1):717-21.
12. Tosti A, Camacho-Martinez F, Dawber R. Management of androgenetic alopecia. J Eur Acad Dermatol Venereol 1999;12:205-14.
13. Bouhanna P, Reygagne P. Pathologie Du Cheveu et Du Cuir Chevelu. Paris: Masson, 1999:350.
14. Bouhanna P, Dardour JC. Hair Replacement Surgery: Textbook and Atlas. Berlin Heidelberg: Springer-Verlag, 1996:236.
15. Bouhanna P. Chirurgie dermatologique esthétique du cuir chevelu, traité cosmétologie et dermatologie esthétique. EMC Paris 2000;50:430:A10.
16. Bouhanna P. Garder et Retrouver Ses Cheveux: Les Nouveaux Traitements. Paris: Springer, 2000:103.
17. Diani AR, Mulholland MJ, Shull KL, et al. Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque. J Clin Endocrinol Metab 1992;74:345-50.
18. Bouhanna P. Topical minoxidil used before and after hair transplantation. J Dermatol Surg Oncol 1989;15:50-3.
19. Bouhanna P. Effects of finasteride and minoxidil 5% on hair growth of mini and micrografts in male androgenetic alopecia. IHRS 7th Annual Meeting, San Francisco, October 20-24, 1999.